A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
Trial details
- Registry ID
- NCT05296629
- Drugs studied
- DFD-29, Doxycycline
TrialRedline tracks 3 clinical trials sponsored by Journey Medical Corporation: 2 Phase 3, 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.NCT05296629 | DFD-29, Doxycycline | Completed | 2023-06-30Actual |
| A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)NCT05343455 | DFD-29, Doxycycline | Completed | 2023-06-30Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary HyperhidrosisNCT02129660 | Dose 1 of glycopyrrolate, 2.0% QD, Dose 1 of glycopyrronium, 2.5% QD, Dose 2 of glycopyrrolate, 3.0% QD, Dose 2 of glycopyrronium, 3.75% QD and 1 more | Completed | 2015-01Actual |
Names as written in the registry records.